These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 10932275
1. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Neurology; 2000 Aug 08; 55(3):397-404. PubMed ID: 10932275 [Abstract] [Full Text] [Related]
2. Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients. Jansson A, Ernerudh J, Kvarnström M, Ekerfelt C, Vrethem M. Mult Scler; 2003 Oct 08; 9(5):440-5. PubMed ID: 14582766 [Abstract] [Full Text] [Related]
3. Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis. Kivisäkk P, Alm GV, Fredrikson S, Link H. Eur J Neurol; 2000 Jan 08; 7(1):27-34. PubMed ID: 10809912 [Abstract] [Full Text] [Related]
4. Interferon beta induces T-helper 2 immune deviation in MS. Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, Zhang JZ. Neurology; 1999 Nov 10; 53(8):1692-7. PubMed ID: 10563614 [Abstract] [Full Text] [Related]
5. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Rohowsky-Kochan C, Molinaro D, Cook SD. Mult Scler; 2000 Apr 10; 6(2):69-77. PubMed ID: 10773850 [Abstract] [Full Text] [Related]
6. Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis. Salama HH, Kolar OJ, Zang YC, Zhang J. Mult Scler; 2003 Feb 10; 9(1):28-31. PubMed ID: 12617264 [Abstract] [Full Text] [Related]
7. Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis. Trenova AG, Manova MG, Kostadinova II, Murdjeva MA, Hristova DR, Vasileva TV, Zahariev ZI. Folia Med (Plovdiv); 2011 Feb 10; 53(2):29-35. PubMed ID: 21797104 [Abstract] [Full Text] [Related]
8. IFN-beta1a and IFN-beta1b have different patterns of influence on cytokines. Sega S, Wraber B, Mesec A, Horvat A, Ihan A. Clin Neurol Neurosurg; 2004 Jun 10; 106(3):255-8. PubMed ID: 15177779 [Abstract] [Full Text] [Related]
10. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H. J Neuroimmunol; 2005 Feb 10; 159(1-2):155-64. PubMed ID: 15652415 [Abstract] [Full Text] [Related]
11. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Brod SA, Marshall GD, Henninger EM, Sriram S, Khan M, Wolinsky JS. Neurology; 1996 Jun 10; 46(6):1633-8. PubMed ID: 8649562 [Abstract] [Full Text] [Related]
12. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. Windhagen A, Anderson DE, Carrizosa A, Balashov K, Weiner HL, Hafler DA. J Neuroimmunol; 1998 Nov 02; 91(1-2):1-9. PubMed ID: 9846813 [Abstract] [Full Text] [Related]
13. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment]. Bongioanni P, Romano MR, Boccardi B, Lombardo F, Moscato G, Mosti S, Baldini C, Nuti S, Meucci G, Rossi B. Rev Neurol; 1998 Nov 02; 29(10):893-9. PubMed ID: 10637835 [Abstract] [Full Text] [Related]
14. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J. Acta Neurol Scand Suppl; 1994 Nov 02; 158():1-58. PubMed ID: 7732782 [Abstract] [Full Text] [Related]
15. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. Vojdani A, Vojdani E, Cooper E. J Intern Med; 2003 Oct 02; 254(4):363-74. PubMed ID: 12974875 [Abstract] [Full Text] [Related]
16. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P. J Neurosci Res; 2001 Feb 01; 63(3):290-302. PubMed ID: 11170179 [Abstract] [Full Text] [Related]
17. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis. Bakhiet M, Ozenci V, Withagen C, Mustafa M, Fredrikson S, Link H. Clin Diagn Lab Immunol; 1999 May 01; 6(3):415-9. PubMed ID: 10225846 [Abstract] [Full Text] [Related]
18. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Hamamcioglu K, Reder AT. Mult Scler; 2007 May 01; 13(4):459-70. PubMed ID: 17463069 [Abstract] [Full Text] [Related]
19. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ. J Neuroimmunol; 1999 Aug 03; 98(2):201-7. PubMed ID: 10430053 [Abstract] [Full Text] [Related]
20. T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis. Ristori G, Montesperelli C, Gasperini C, Battistini L, Borsellino G, Buttinelli C, Cannoni S, Perna A, Pozzilli C, Salvetti M. J Neuroimmunol; 1999 Sep 01; 99(1):91-6. PubMed ID: 10496181 [Abstract] [Full Text] [Related] Page: [Next] [New Search]